Elise Baumgarten litigates civil and criminal cases, with an emphasis on patent and complex commercial disputes. As part of Elise's patent litigation practice, she has represented clients in Hatch-Waxman litigation, in inter partes review proceedings before the United States Patent and Trademark Office (USPTO), and disputes dealing with the intersection of patent and antitrust law. Elise also has experience in a range of other substantive areas, including white-collar criminal defense, accounting malpractice, trade secrets and restrictive covenants, First Amendment, and commercial disputes.
In 2024, Elise was named a "Life Sciences Rising Star" by Law360. She has also been recognized as a “Legal Lion” by Law360, and, in 2022, LMG Life Sciences identified Elise among the finalists for the “US Rising Star—Intellectual Property” award. Both in September 2022 and May 2021, The American Lawyer recognized Elise as a “Litigator of the Week Runner Up” for successfully representing Merck in a major trial victory and IPR proceedings, respectively, concerning patents covering the blockbuster sitagliptin products: Januvia, Janumet, and Janumet XR.
A native of Atlanta, Georgia, Elise graduated summa cum laude with both a Bachelors and Master’s Degree in Political Science from Emory University. She then earned a law degree, with honors, from Harvard Law School, where she served as an Articles Editor for the Harvard Law Review. She joined the firm in 2011, after clerking for the Honorable Paul V. Niemeyer of the Fourth Circuit. Elise currently serves as a member of the firm's Hiring Committee.
Updated Aug 2024
